Technology
Health
Biotechnology

Wave Life Sciences

$22.63
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.53 (-2.29%) Today
$0.00 (0.00%) As of 4:27 PM EDT after-hours

Why Robinhood?

You can buy or sell WVE and other stocks, options, ETFs, and crypto commission-free!

About WVE

Wave Life Sciences Ltd. Ordinary Shares, also called Wave Life Sciences, is a biotechnology company, which engages in the development of proprietary synthetic chemistry drug. Read More It focuses on the design, development, and commercialization of nucleic acid-based therapeutics. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Employees
250
Headquarters
Singapore, Central Singapore
Founded
2012
Market Cap
793.36M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
201.07K
High Today
$23.36
Low Today
$22.47
Open Price
$23.32
Volume
290.43K
52 Week High
$56.00
52 Week Low
$22.25

Collections

Technology
Health
Biotechnology
Therapy
2015 IPO
Asia (Non-China)
Asia

WVE Earnings

-$1.36
-$1.07
-$0.78
-$0.49
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.